Teslexivir
Teslexivir (BTA074) is a potent antiviral agent. Teslexivir is a potent and selective inhibitor of the interaction between two essential viral proteins, E1 and E2, an association that is a necessary step in the DNA replication and thus viral production for Human Papilloma Virus (HPV) 6 and 11. Teslexivir can be used for condyloma research[1].
Product Specifications
CAS Number
1075798-37-6
Product Name Alternative
BTA074; AP 611074
UNSPSC
12352005
Target
E1/E2/E3 Enzyme; HPV
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Teslexivir.html
Solubility
10 mM in DMSO
Smiles
O=C(CC1=CC(OC)=C(C(O)=O)C=C1Br)NN(C2=CC=C(CC3=CC=CC=C3)C=C2)C4=C(N5CCCCC5)C=CC=C4C
Molecular Formula
C35H36BrN3O4
Molecular Weight
642.58
References & Citations
[1]Atta-ur-Rahman. Frontiers in Clinical Drug Research - Anti Infectives: Volume 8. 2021, 8, 55-100.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Explore Other Products
Browse additional items from our catalog
Dihydropyrimidinase Polyclonal Antibody, APC-Cy5.5 Conjugated
Stk36 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)